Similar articles

• A modest proposal: toward improved access to biotechnology research tools by implementing a broad experimental use exception.

  Hoffman DC. Hoffman DC. Cornell Law Rev. 2004 May;89(4):993-1043. Cornell Law Rev. 2004. PMID: 15174465 No abstract available.
• Rights, patents, markets and the global AIDS pandemic.

  Gathii JT. Gathii JT. Fla J Int Law. 2002 Spring;14(2):261-352. Fla J Int Law. 2002. PMID: 16526139 No abstract available.
• Alienation from the Objectives of the Patent System: How to Remedy the Situation of Biotechnology Patent.

  Jiang L. Jiang L. Sci Eng Ethics. 2019 Jun;25(3):791-811. doi: 10.1007/s11948-018-0043-3. Epub 2018 Mar 12. Sci Eng Ethics. 2019. PMID: 29532279
• Patenting basic research: myths and realities.

  Kirschenbaum SR. Kirschenbaum SR. Nat Neurosci. 2002 Nov;5 Suppl:1025-7. doi: 10.1038/nn932. Nat Neurosci. 2002. PMID: 12403976 Review. No abstract available.
• The global health system: linking knowledge with action--learning from malaria.

  Keusch GT, Kilama WL, Moon S, Szlezák NA, Michaud CM. Keusch GT, et al. PLoS Med. 2010 Jan 19;7(1):e1000179. doi: 10.1371/journal.pmed.1000179. PLoS Med. 2010. PMID: 20087415 Free PMC article. Review.